Testing effectiveness (Phase 2)Study completedNCT00132015
What this trial is testing
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis
Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
National Institutes of Health Clinical Center (CC) 37